Literature DB >> 21859980

Is diabetes the achilles' heel of limus-eluting stents?

Adnan Kastrati, Steffen Massberg, Gjin Ndrepepa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21859980     DOI： 10.1161/CIRCULATIONAHA.111.049544

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

Review 1.  Coronary Stents in Diabetic Patients: State of the Knowledge.

Authors:  Pablo Codner; Hitinder Singh Gurm; Apurva Motivala
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

2.  Clinical Outcomes in Diabetic Patients Who Underwent Percutaneous Coronary Intervention during the Plain Old Balloon Angioplasty (POBA)-, Bare Metal Stents (BMS)- and Drug-eluting Stents (DES)-eras from 1984 to 2010.

Authors:  Ryo Naito; Katsumi Miyauchi; Hirokazu Konishi; Shuta Tsuboi; Manabu Ogita; Tomotaka Dohi; Takatoshi Kasai; Hiroshi Tamura; Shinya Okazaki; Kikuo Isoda; Hiroyuki Daida
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

3.  Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents.

Authors:  Juan F Iglesias; Dik Heg; Marco Roffi; David Tüller; Jonas Lanz; Fabio Rigamonti; Olivier Muller; Igal Moarof; Stéphane Cook; Daniel Weilenmann; Christoph Kaiser; Florim Cuculi; Marco Valgimigli; Peter Jüni; Stephan Windecker; Thomas Pilgrim
Journal:  J Am Heart Assoc       Date:  2019-11-07       Impact factor: 5.501

4.  Efficacy of Zotarolimus-Eluting Stents in Treating Diabetic Coronary Lesions: An Optical Coherence Tomography Study.

Authors:  Zhengbin Zhu; Jinzhou Zhu; Run Du; Haotian Zhang; Jinwei Ni; Weiwei Quan; Jian Hu; Fenghua Ding; Zhenkun Yang; Ruiyan Zhang
Journal:  Adv Ther       Date:  2020-03-07       Impact factor: 3.845

Review 5.  Everolimus-eluting stents in interventional cardiology.

Authors:  Jacob C Townsend; Phillip Rideout; Daniel H Steinberg
Journal:  Vasc Health Risk Manag       Date:  2012-06-27

6.  Dysregulation of the Mammalian Target of Rapamycin and p27Kip1 Promotes Intimal Hyperplasia in Diabetes Mellitus.

Authors:  Thomas Cooper Woods
Journal:  Pharmaceuticals (Basel)       Date:  2013-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.